Search research articles
Contact Us
Filters
Showing results (141-150 of 217) with videos related to
Page
of 22
Sort By:
The Journal of Urology
|
May 1, 1990
Pathophysiology of urinary incontinence after radical prostatectomy
J C Presti, R A Schmidt, P A Narayan, et al.
Radiology
|
March 1, 1991
Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses
R C Semelka, H Hricak, S K Stevens, et al.
Human Pathology
|
July 1, 1993
Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder
M B Cohen, F M Waldman, P R Carroll, et al.
Radiology
|
March 1, 1988
Detection and staging of renal neoplasms: a reassessment of MR imaging
H Hricak, R F Thoeni, P R Carroll, et al.
The Journal of Urology
|
August 1, 1997
Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy
J A Connolly, J C Presti, M L Cher, et al.
Urology
|
December 1, 1993
Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis
J S Wolf, K Shinohara, K M Kerlikowske, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 1, 1993
5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder
F M Waldman, P R Carroll, M B Cohen, et al.
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology
|
January 1, 1984
A comparative study of properties and toxic constituents of funnel web spider (Atrax) venoms
D D Sheumack, B A Baldo, P R Carroll, et al.
Radiology
|
October 1, 1994
Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging
B Kim, R C Semelka, S M Ascher, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer
D F Penson, M S Litwin, D P Lubeck, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 217) with videos related to
Sort By:
Page
of 22
The Journal of Urology
|
May 1, 1990
Pathophysiology of urinary incontinence after radical prostatectomy
J C Presti, R A Schmidt, P A Narayan, et al.
Radiology
|
March 1, 1991
Combined gadolinium-enhanced and fat-saturation MR imaging of renal masses
R C Semelka, H Hricak, S K Stevens, et al.
Human Pathology
|
July 1, 1993
Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder
M B Cohen, F M Waldman, P R Carroll, et al.
Radiology
|
March 1, 1988
Detection and staging of renal neoplasms: a reassessment of MR imaging
H Hricak, R F Thoeni, P R Carroll, et al.
The Journal of Urology
|
August 1, 1997
Accelerated tumor proliferation rates in locally recurrent prostate cancer after radical prostatectomy
J A Connolly, J C Presti, M L Cher, et al.
Urology
|
December 1, 1993
Selection of patients for laparoscopic pelvic lymphadenectomy prior to radical prostatectomy: a decision analysis
J S Wolf, K Shinohara, K M Kerlikowske, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 1, 1993
5-Bromodeoxyuridine incorporation and PCNA expression as measures of cell proliferation in transitional cell carcinoma of the urinary bladder
F M Waldman, P R Carroll, M B Cohen, et al.
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology
|
January 1, 1984
A comparative study of properties and toxic constituents of funnel web spider (Atrax) venoms
D D Sheumack, B A Baldo, P R Carroll, et al.
Radiology
|
October 1, 1994
Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging
B Kim, R C Semelka, S M Ascher, et al.
Prostate Cancer and Prostatic Diseases
|
December 24, 2002
Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer
D F Penson, M S Litwin, D P Lubeck, et al.
Page
of 22